Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ليس لابوراتوريز سيرفيرfiledCriticalليس لابوراتوريز سيرفير
Priority to JO2006338ApriorityCriticalpatent/JO2518B1/en
Application grantedgrantedCritical
Publication of JO2518B1publicationCriticalpatent/JO2518B1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Saccharide Compounds
(AREA)
Abstract
Process for the synthesis of ivabradine of formula (1) Addition salts thereof with a pharmaceutically acceptable acid, and hydrated thereof. A crystalline form of ivabradine hydrochloride. Medicaments
JO2006338A2006-09-262006-09-26New process for the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid
JO2518B1
(en)
New process for the synthesis of (1s)-4, 5-dimethoxy -1- (methylaminomethyl) -benzocyclobutane and addition salts thereof, and application in the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid.
New process for the synthesis of 7,8-dimethoxy-1,3-dihydro-2h-3-benzazepin-2- one, and application in the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid
Process for the synthesis of 1,3,4,5-tetrahydro-3-benzazepin-2-one compounds, and application in the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid
Process for the synthesis of 1,3-dihydro-2h-3-benzazepin-2-one compounds, and application in the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid